Free Trial

Cano Health (CANO) Stock Forecast & Price Target

Notice: This company has been marked as potentially delisted and may not be actively trading.

Cano Health - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 3 Wall Street analysts who have issued ratings for Cano Health in the last 12 months, the stock has a consensus rating of "Reduce." Out of the 3 analysts, 1 has given a sell rating, and 2 have given a hold rating for CANO.

Consensus Price Target

$2.28
High Forecast$3.75
Average Forecast$2.28
Low Forecast$0.80

According to the 3 analysts' twelve-month price targets for Cano Health, the average price target is $2.28. The highest price target for CANO is $3.75, while the lowest price target for CANO is $0.80. .

TypeCurrent Forecast
7/25/23 to 7/24/24
1 Month Ago
6/25/23 to 6/24/24
3 Months Ago
4/26/23 to 4/25/24
1 Year Ago
7/25/22 to 7/25/23
Consensus Rating
Reduce
Reduce
Reduce
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
1 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
7 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$2.28$2.28$1.85$3.09
Forecasted UpsideN/A-54.39% Downside-56.41% Downside21.93% Upside
Get Cano Health Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CANO and its competitors with MarketBeat's FREE daily newsletter.

CANO Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CANO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Cano Health Stock vs. The Competition

TypeCano HealthMedical CompaniesS&P 500
Consensus Rating Score
1.67
2.72
2.51
Consensus RatingReduceModerate BuyModerate Buy
Predicted Upside2,973.34% Upside9.72% Upside
News Sentiment RatingNeutral News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/17/2023UBS Group
4 of 5 stars
 Reiterated RatingNeutral ➝ Sell$12.00 ➝ $3.75-55.62%
8/11/2023Jefferies Financial Group
2 of 5 stars
 DowngradeBuy ➝ Hold
8/11/2023Citigroup
3 of 5 stars
 DowngradeBuy ➝ Neutral$4.00 ➝ $0.80-47.54%
5/16/2023Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$1.00-21.26%
1/5/2023Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Peer Perform
12/13/2022Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingUnderperform$1.50+6.38%
11/28/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$4.00+136.69%
11/10/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform$10.00 ➝ $3.00+35.13%
11/10/2022Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
John Ransom
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform
9/7/2022Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageHold$7.00+19.05%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 05:15 AM ET.

CANO Forecast - Frequently Asked Questions

What is Cano Health's forecast for 2024?

According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for Cano Health is $2.28, with a high forecast of $3.75 and a low forecast of $0.80.

Should I buy or sell Cano Health stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cano Health in the last year. There is currently 1 sell rating and 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "reduce" CANO shares.

Does Cano Health's stock price have much downside?

According to analysts, Cano Health's stock has a predicted downside of -54.39% based on their 12-month stock forecasts.

Do Wall Street analysts like Cano Health more than its competitors?

Analysts like Cano Health less than other "medical" companies. The consensus rating for Cano Health is Reduce while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how CANO compares to other companies.


This page (NYSE:CANO) was last updated on 7/24/2024 by MarketBeat.com Staff

From Our Partners